Trial intelligence / Profile preview

Pollen+ Study of Grazax for Seasonal Rhinitis

NCT02005627Phase 2Completed

Sponsor
Imperial College London
Start
Sep 2013
Primary completion
Mar 2017
Modality
Biologic
Countries
1
01

Overview

A Phase 2 trial of phleum pratense allergen extract in allergic rhinitis (AR), sponsored by Imperial College London. Started Sep 2013; status: completed.

02

Drugs

phleum pratense allergen extract
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT02005627.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02005627.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call